Evaluation of the Efficacy of a Live Fowlpox-Vectored Infectious Laryngotracheitis/Avian Encephalomyelitis Vaccine Against ILT Viral Challenge
- 1 March 2006
- journal article
- research article
- Published by American Association of Avian Pathologists (AAAP) in Avian Diseases
- Vol. 50 (1), 50-54
- https://doi.org/10.1637/7398-062105r.1
Abstract
Infectious laryngotracheitis (ILT) is caused by an alphaherpesvirus, and latency can be produced by previous exposure to vaccine virus. The main sites of latency for the ILT virus have been shown to be the trigeminal ganglion and the trachea. Reactivation of latent virus is one factor related to the production of clinical signs. The development of a genetically engineered ILT vaccine has been suggested for many years as a tool to eliminate viral latency. Several approaches have been suggested. Included among them is the development of a thymidine kinase-deficient mutant or the insertion of ILT viral glycoproteins into a viral vector such as a poxvirus. A commercially available, live, fowlpox-vectored infectious laryngotracheitis + avian encephalomyelitis (FP-LT+AE) vaccine was used in field trials in leghorn pullet flocks and evaluated by tracheal challenge in a laboratory setting with the use of the National Veterinary Services Laboratory (Ames, IA) ILT challenge virus. Interference of the pigeon pox vaccine, which is often administered concurrently with fowlpox vaccine, was also evaluated when given in conjunction with the FP-LT+AE vaccine. Overall, the results indicate that the FP-LT+AE vaccine provides adequate protection against ILT viral challenge. Proper administration is essential. In one flock, inadequate protection was most likely a result of either poor vaccine administration or previous exposure to pox virus. In addition, the simultaneous administration of pigeon pox vaccine did not appear to interfere with protection against ILT viral challenge.Keywords
This publication has 16 references indexed in Scilit:
- Pathogenicity and vaccine efficacy of a thymidine kinase gene deleted infectious laryngotracheitis virus expressing the green fluorescent protein geneArchiv für die gesamte Virusforschung, 2002
- Protection of chickens from infectious laryngotracheitis with a recombinant fowlpox virus expressing glycoprotein B of infectious laryngotracheitis virusAvian Pathology, 2001
- Protection against diverse highly pathogenic H5 avian influenza viruses in chickens immunized with a recombinant fowlpox vaccine containing an H5 avian influenza hemagglutinin gene insertVaccine, 2000
- Avian infectious laryngotracheitis: Virus‐host interactions in relation to prospects for eradicationAvian Pathology, 1995
- Demonstration of sites of latency of infectious laryngotracheitis virus using the polymerase chain reactionJournal of General Virology, 1992
- Vaccination with affinity‐purified glycoproteins protects chickens against infectious laryngotracheitis herpesvirusAvian Pathology, 1991
- Latency and reactivation of infectious laryngotracheitis vaccine virusArchiv für die gesamte Virusforschung, 1991
- Insertion of the fusion gene from Newcastle disease virus into a non-essential region in the terminal repeats of fowlpox virus and demonstration of protective immunity induced by the recombinantJournal of General Virology, 1990
- Protective immunity against avian influenza induced by a fowlpox virus recombinantVaccine, 1988
- Laryngotracheitis (gallid‐1) herpesvirus infection in the chicken 4. latency establishment by wild and vaccine strains of ILT virusAvian Pathology, 1986